Humana stock bounces after Medicare Advantage rate shock; what traders are watching next
Humana Inc. shares gained roughly 1.5%, reaching $196.94 by Thursday afternoon, following a close of $194.01 on Wednesday.
Humana stock sinks again as Medicare Advantage rate shock keeps HUM under pressure
Humana shares fell 6.69% to close at $194.01 on Wednesday, deepening losses amid a broader selloff triggered by U.S. Medicare Advantage payment proposals.
Dow Jones flattens near 49,000 as S&P 500 hits 7,000; Fed and Big Tech earnings loom
The Dow Jones Industrial Average stayed close to unchanged on Wednesday as the S&P 500 briefly climbed above 7,000 before slipping back. Investors were on edge ahead of the Federal Reserve’s rate announcement and a slew of megacap earnings reports. By 11:31 a.m. ET, the Dow had edged up 49.62 points, or 0.10%, to 49,053.03. Chip stocks drove early gains, with Intel soaring 11.3%.
Humana stock slides again as Medicare Advantage rate proposal keeps pressure on insurers
Shares of Humana Inc dropped roughly 6% on Wednesday, extending the insurer’s struggles following a steep two-day selloff in Medicare Advantage-related health plans. The stock slipped to $195.31, down 6.1%, after starting the day at $206.51.
Dow Jones today: Dow hovers near 49,000 as Fed decision and mega-cap earnings loom
The Dow Jones Industrial Average held steady on Wednesday morning, lingering near 49,000 as traders eyed the Federal Reserve and a flurry of late-day earnings reports from major companies. By 10:26 a.m. EST, the blue-chip index dipped 3.56 points, or 0.01%, to 48,999.85. Meanwhile, the S&P 500 inched up 0.16%, and the Nasdaq climbed 0.39%.
Dow Jones today: Dow futures inch up as Fed decision and Big Tech earnings loom
Dow Jones Industrial Average futures climbed roughly 30 points early Wednesday, while S&P 500 and Nasdaq 100 futures showed modest gains. These contracts, traded outside normal sessions, often signal possible market openings.
Humana stock price tumbles 21% after Medicare Advantage rate proposal — what to watch next
Humana Inc shares tumbled 21.1% to $207.93 in after-hours trading Tuesday, following a steep sell-off earlier in the session. The stock swung between $231.79 and $206.25 during the day, with roughly 10.4 million shares changing hands.
UnitedHealth Group stock price tumbles: UNH slides nearly 20% after outlook, Medicare Advantage rates in focus
Shares of UnitedHealth Group Incorporated dropped 19.5%, closing at $282.90 in late New York trading on Tuesday, after fluctuating between $323.67 and $280.40.
UnitedHealth stock tumbles nearly 20% as Medicare Advantage rate proposal rattles UNH investors
Shares of UnitedHealth Group Incorporated dropped 18.4% to $286.96 in Tuesday morning trading, as investors digested a rate shock in Medicare Advantage and its potential impact on 2027 earnings power.
Dow Jones drops 450 points as UnitedHealth sinks on Medicare rates; confidence slumps
The Dow Jones Industrial Average fell 445.67 points, or 0.90%, to 48,966.73 by 10:05 a.m. ET, underperforming the wider market. The S&P 500 climbed 0.37%, while the Nasdaq Composite rose 0.81%.
Why UnitedHealth stock fell today: UNH slides as Medicare Advantage spotlight returns
Shares of UnitedHealth Group Incorporated dropped 2.3%, closing at $331.02 in after-hours trading on Friday.
UnitedHealth stock drops today — what traders are watching before UNH earnings
UnitedHealth Group Incorporated shares dipped roughly 1.3% on Friday, closing at $334.40. As the Dow pulled back, the largest health insurer by market cap turned into one of its biggest drags.
UnitedHealth (UNH) stock slips as Senate report puts Medicare Advantage under the microscope
Shares of UnitedHealth Group Incorporated dropped nearly 2% Tuesday, deepening a retreat sparked by a U.S. Senate report scrutinizing how the insurer logs diagnoses in Medicare Advantage. Humana, Elevance Health, and Cigna also saw declines.
UnitedHealth stock falls despite new price targets as Wall Street eyes Jan. 27 earnings
UnitedHealth Group Incorporated shares fell more than 2% on Wednesday, tracking a broader retreat in managed-care insurers. The stock was down $8.53 at $340.44 in late morning trading, while Humana slid 1.4% and Cigna dropped 2.1%.
UnitedHealth stock ticks up after Barclays target hike as UNH earnings near
UnitedHealth Group Inc shares were up 0.8% at $338.94 in late-morning trading on Monday after Barclays raised its price target on the health insurer. The stock has traded between $333.86 and $340.29 so far, with about 2.4 million shares changing hands.
UnitedHealth stock rises into the weekend — what UNH investors watch before Jan. 27 results
UnitedHealth Group shares ended Friday up 1.9% at $336.40, closing out the first session of the year with a firm tone in managed care.
UnitedHealth stock today: UNH rises after hours as traders look ahead to January guidance
UnitedHealth Group shares were up about 1% at $332.16 in after-hours trading on Tuesday, following the 4 p.m. close. The stock ranged from $329.18 to $336.03 during the day’s session, with about 4.4 million shares traded.
UnitedHealth Group (UNH) Stock After Hours Today (Dec. 15, 2025): Key News, Analyst Forecasts, and What to Watch Before Tuesday’s Open
UnitedHealth Group Incorporated finished Monday’s regular session modestly lower and then drifted a touch further in after-hours trading—setting up a “watch-the-macro” Tuesday morning for managed-care investors.
Humana Stock (HUM) Outlook December 4, 2025: Earnings Beat, Legal Risks and 2026 Medicare Advantage Forecast
Humana’s share price spent most of 2025 behaving like a stressed-out cardiogram: sharp drops around guidance cuts and star-rating headlines, then sharp rebounds when the numbers looked less bad than feared.
PSTV Stock on November 25, 2025: FDA Meeting, Nasdaq Extension and Humana Deal Put Plus Therapeutics Back in Focus
As traders log in on Tuesday, November 25, 2025, Plus Therapeutics is back on the radar thanks to a cluster of late‑November catalysts: an FDA Type B meeting for lead radiotherapeutic REYOBIQ™, a fresh 180‑day Nasdaq bid‑price extension, and a national coverage agreement with Humana for its CNSide® cancer diagnostic.